SURG · trading date Oct 12, 2026 · previous close $0.14 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$56.96M
Net income
-$36.07M
Total assets
$8.52M
Total liabilities
$23.92M
Stockholders' equity
-$15.35M
Cash & equivalents
$1.73M
Operating income
-$34.14M
Operating cash flow
-$21.29M
Capital expenditures
$18.6K
Fiscal year 2025, via 10-K filed 2026-04-15.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-59.9%
Net margin
-63.3%
Free cash flow
-$21.31M
Free cash flow margin
-37.4%
Liabilities / assets
280.9%
Equity / assets
-180.2%
CapEx / revenue
0.0%
Operating cash flow / net income
0.59×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Bartlett, TN 38133
3124 BROTHER BLVD
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:54 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.